Benzinga | May 10, 2021 04:18PM EDT

Castle Biosciences Q1 EPS $(0.17) Beats $(0.24) Estimate, Sales $22.80M Beat $16.66M Estimate

Castle Biosciences (NASDAQ:CSTL) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.24) by 29.17 percent. This is a 666.67 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $22.80 million which beat the analyst consensus estimate of $16.66 million by 36.85 percent. This is a 30.90 percent increase over sales of $17.42 million the same period last year.